Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria

Journal of Inherited Metabolic Disease

Volumn 27, Issue 2, 2004, Pages 137-143

  Arnold, Georgianne L ^a   Vladutiu, C J ^a   Orlowski, C C ^a   Blakely, E M ^a   DeLuca, J ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; PHENYLALANINE;

ADOLESCENT; ADULT; AGE; AMINO ACID BLOOD LEVEL; ATTENTION DEFICIT DISORDER; CHILD; CHILD CARE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENDER; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEDICAL RECORD; METABOLIC DISORDER; PHENYLKETONURIA; PREVALENCE; REVIEW;

ADOLESCENT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; FEMALE; HUMANS; MALE; PHENYLALANINE; PHENYLKETONURIAS; PREVALENCE; RETROSPECTIVE STUDIES; TYROSINE;

EID: 2942585422     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BOLI.0000028725.37345.62     Document Type: Review

References (25)

1. Arnsten AF (2000) Genetics of childhood disorders: XVIII. ADHD, part 2: Norephinephrine has a critical modulatory influence on prefrontal cortical function. J Am Acad Child Adolesc Psychiatry 39: 1201-1202.
2. Barkley RA (1997) Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 12: 65-94.
3. Biederman J, Faraone S, Mick E (1999) Clinical correlates of ADHD in females: findings from a large group of girls ascertained from pediatric and psychiatric referral sources. J Am Acad Child Adolesc Psychiatry 38: 966-975.
4. Burgard P, Armbruster M, Schmidt E, Rupp A (1994) Psychopathology of patients treated early for phenylketonuria: results of the German collaborative study of phenylketonuria. Acta Paediatr Suppl 407: 108-110.
5. Comings DE, Gade-Andavolu R, Ganzalez N, (2000) Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet 57: 178-196.
6. Crandall EA, Fernstrom JD (1983) Effect of experimental diabetes on the levels of aromatic and branched-chain amino acids in rat blood and brain. Diabetes 32: 222-230.
7. Diamond A (1996) Evidence for the importance of dopamine for prefrontal cortex functions early in life. Philos Trans R Soc (London) B Biol Sci 351: 1483-1494.
8. Diamond A, Ciaramitaro V, Doner E, Djali S, Robinson M (1994) An animal model of early-treated PKU. J Neurosci 14: 3072-3082.
9. Diamond A, Prevor MB, Callender G, Druin DP (1997) Prefrontal cortex cognitive deficits in children treated early and continuously for PKU. Monogr Soc Res Child Dev Serial 252: 62.
10. Kalverboer AF, van der Schot LWA, Hendrikx MMH, Huisman J, Slijper FME, Stemerdink BA (1994) Social behavior and task orientation in early-treated PKU. Acta Paediatr Suppl 407: 104-105.
11. Lou HC, Guttler F, Lykkelund C, Bruhn P, Niederwieser A (1995) Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents. Eur J Pediatr 144: 17-20.
12. Pliszka SR, McCracken JT, Mass JW (1996) Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiatry 35: 264-272.
13. Realmuto GM, Garfinkel BD, Tuchman M, et al (1986) Psychiatric diagnosis and behavioral characteristics of phenylketonuric children. J Nerv Ment Dis 74: 536-540.
14. Schmidt E, Rupp A, Burgard P, Pietz J, Weglage J, de Sonneville LMJ (1994) Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood level. J Clin Exp Neuropsychol 16: 681-688.
15. Smith I, Knowles J (2000) Behavior in early treated phenylketonuria: a systematic review. Eur J Pediatr 159: S89-S93.
16. Smith I, Beasly MG, Wolff OH, Ades AE (1988) Behavior disturbance in 8 year old children with early treated phenylketonuria. J Pediatr 112: 403-408.
17. Smith ML, Klim P, Hanley WB (2000) Executive function in school-aged children with pherylketonuria. J Dev Phys Disabil 12: 317-332.
18. Spreen O, Risser AH, Edgell D (1995) Developmental Neuropsychology. New York: Oxford University Press.
19. Stemerdink BA, van der Meere JJ, van der Molen MW, et al (1995) Information processing in patients with early and continuously treated phenylketonuria. Eur J Pediatr 14: 739-736.
20. Stemerdink NBA, van der Molen MW, Kalverboer AF, et al (1999) Prefrontal dysfunction in early and continuously treated phenylketonuria. Dev Neuropsychol 16: 29-57.
21. Surtees R, Blau N (2000) The neurochemistry of phenylketonuria. Eur J Pediatr 159: S109-S113.
22. Swanson J, Castellanos FX, Murias M, LaHoste G, Kennedy J (1998) Cognitive neuroscience of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol 8: 263-271.
23. Waisbren SE, Varvogli L, Warger-Rogers J, Levy HL (1997) Attention deficits and hyperactivity in early treated phenylketonuria. Workshop Presentation at the 7th International Congress of Inborn Errors of Metabolism, Vienna, Austria, May 22.
24. Welsh MC, Pennington BF, Ozonoff S, Rouse B, McCabe ERB (1990) Neuropsychology of early treated phenylketonuria. Specific executive function deficits. Child Dev 61: 1697-1713.
25. White DA, Nortz MJ, Mandernach T, Huntington K, Steiner RD (2002) The emergence of working memory impairments in children with prefrontal dysfunction related to phenylketonuria. J Int Neuropsychol Soc 1: 1-11.